Drug Therapy of Postprandial Hyperglycaemia
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 57 (1) , 19-29
- https://doi.org/10.2165/00003495-199957010-00003
Abstract
It is widely accepted that the most challenging goal in the management of patients with diabetes mellitus is to achieve blood glucose levels as close to normal as possible. In general, normalising...This publication has 88 references indexed in Scilit:
- Potential of ??-Glucosidase Inhibitors in Elderly Patients with Diabetes Mellitus and Impaired Glucose ToleranceDrugs & Aging, 1998
- Reduced Frequency of Severe Hypoglycemia and Coma in Well-Controlled IDDM Patients Treated With Insulin LisproDiabetes Care, 1997
- PROTECT interim results: a large multicenter study of patients with type II diabetesClinical Therapeutics, 1997
- Stimulation of Insulin Release by Non-Sulfonylurea Hypoglycemic Agents: The Meglitinide FamilyHormone and Metabolic Research, 1995
- AcarboseDrugs, 1993
- Postprandial triglyceridemia and carotid atherosclerosis in middle-aged subjects.Stroke, 1992
- Amylin concentrations and glucose controlThe Lancet, 1992
- Therapeutic Potentials of Acarbose as First-Line Drug in NIDDM Insufficiently Treated With Diet AloneDiabetes Care, 1991
- Plasma Insulin as Coronary Heart Disease Risk Factor: Relationship to other Risk Factors and Predictive Value during 9½‐year Follow‐up of the Helsinki Policemen Study PopulationActa Medica Scandinavica, 1985
- Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatmentDiabetologia, 1980